J Biol Chem, Vol. 274, Issue 34, 24401-24407, August 20, 1999
An Enhancer Element for Expression of the Ncx
(Enx, Hox11L1) Gene in Neural Crest-derived
Cells*
Yoshinori
Iitsuka
§,
Hironori
Shimizu
,
Myeng M.
Kang
,
Kazushi
Sasagawa
,
Souei
Sekiya§,
Takeshi
Tokuhisa
, and
Masahiko
Hatano
¶
From the
Department of Developmental Genetics, Chiba
University Graduate School of Medicine, Chiba 260-8670, Japan and the
§ Department of Obstetrics and Gynecology, Chiba University
School of Medicine, Chiba 260-8670, Japan
 |
ABSTRACT |
The murine Ncx (Enx,
Hox11L1) gene is specifically expressed in a neuronal
subset of neural crest-derived tissues. In attempts to elucidate the
regulatory DNA element of the tissue-specific expression, we sequenced
the 5'-flanking region of the Ncx gene. The transcriptional
initiation site was determined at 297 nucleotides (
297) upstream from
the ATG start codon (+1). A retinoic acid response element was located
on the region between
1163 and
1150. Transient transfection assays
with the 5'-flanking sequences fused to the luciferase gene showed that
the region between
1387 and
1368 was crucial for the
tissue-specific enhancer activity. Furthermore, nuclear proteins
extracted from neural crest-derived cells such as murine and human
neuroblastoma cells bind to the DNA region between
1387 and
1368.
This DNA element was also conserved in the 5'-flanking region of the
human NCX gene. Our observations strongly suggest that the
DNA element (between
1387 and
1368) contributes to tissue-specific
expression of the Ncx gene in murine and human species.
 |
INTRODUCTION |
The mammalian homeobox (Hox) genes encode proteins
containing a conserved 60-amino acid sequence (homeodomain) originally identified in Drosophila (1). In humans and mice, many of
the Hox genes are clustered on four different chromosomes
(HoxA, -B, -C, and -D), and
each cluster retains a linear arrangement of the gene that is similar
to its Drosophila counterpart. Expression of each
Hox gene in the cluster is strictly regulated temporally and
spatially during embryogenesis, and the gene located on the more 3'
side of the cluster is expressed in the more anterior part of mouse
embryo. Those clustered Hox genes play an important role in
specification of position along axes in the developing embryo
(1). In addition to clustered Hox genes, some Hox
genes do not locate in those four cluster regions. Expression of the orphan Hox genes is also tightly regulated temporally and
spatially during embryogenesis.
The murine Ncx/Enx/Hox11L1 gene (2, 3), a member of the
Hox11 gene family (4-7) that locates outside Hox
gene clusters (8), is expressed specifically in neural crest-derived
tissues such as dorsal root ganglia, cranial ganglia (V, IX, and
X), sympathetic ganglia, adrenal medulla, and enteric ganglia (9, 10).
Neural crest cells arise from the dorsal part of neural tube and
migrate along a number of defined routes to various tissues from
embryonic day 9.5. These neural crest cells mainly differentiate into
neuronal cells in the peripheral nervous system, melanocytes, and
cephalic mesenchymal cells such as smooth muscle and cartilage (11). Since the Ncx mRNA has not been detected in the cell
lineage of melanocytes and mesenchymal cells (9), it is apparently
specifically expressed in a neuronal subset of neural crest-derived
tissues. The regulatory mechanisms of expression have remained to be identified.
Deregulated expression of the HOX genes can be oncogenic in
humans (5, 12, 13). Mice with mutations in Hox genes also have a variety of congenital anomalies resembling human genetic diseases. For example, mice deficient for the Ncx gene
developed megacolon with the hyperinnervation of enteric neurons in the narrow segment of megacolon (10, 14). This phenotype resembles the
human disease known as neuronal intestinal dysplasia. Therefore, a
detailed analysis of regulatory mechanisms of Hox gene
expression is required to better understand the genetic basis of such
disease in humans.
To examine molecular mechanisms underlying the regulation of
Ncx gene expression, we sequenced 5'-flanking regions of the murine and the human Ncx gene; both have a retinoic acid
response element (RARE).1
Furthermore, the enhancer element necessary for tissue-specific expression was identified in the 5'-flanking region by transient transfection of the murine Ncx promoter-luciferase chimeric
genes into neuroblastoma cells. The element was also conserved in the human NCX gene. We also demonstrate that nuclear proteins
from neural crest-derived cells such as neuroblastoma and melanoma cells (but not from fibroblast cells) bind to the enhancer element. The
regulatory region of tissue-specific expression of the Ncx gene is discussed.
 |
EXPERIMENTAL PROCEDURES |
Animals--
(C57BL/6 × DBA/2) F1 female mice were
purchased from Japan SLC Co. Ltd. (Hamamatsu, Japan). The midday
following the plugging was defined as embryonic day 0.5.
Cell Culture--
C1300 (Neuro-2A) murine neuroblastoma cells,
B16 murine melanoma cells, and five kinds of human neuroblastoma cells
(SH-SY5Y (15), SMS-KCN (16), SK-N-AS (17), and NBTM and
GANB2) were cultured in RPMI
1640 medium (Life Technologies, Inc.) with 10% fetal calf serum
(Bioserum, CSL Ltd.) at 37 °C under 5% CO2. L mouse
fibroblast cells were maintained in Dulbecco's modified Eagle's
medium (Life Technologies, Inc.) with 5% fetal calf serum.
All-trans-retinoic acid (RA; Sigma) was dissolved in ethanol
at a 10 mM concentration. RA was added to the medium in a
volume corresponding to 0.1% (10 µM) of the culture medium.
Northern Blot Analysis--
Total RNAs were extracted from
murine embryos and several cell lines using the Trizol reagent (Life
Technologies, Inc.). Total RNAs (15 µg) were electrophoresed through
a 1.0% agarose gel containing formaldehyde, transferred to a nylon
membrane (Roche Molecular Biochemicals). The filter was hybridized
overnight at 50 °C in 50% formamide hybridization buffer with 0.5%
SDS, 1% blocking reagent, and the digoxigenin (DIG)-labeled murine
Ncx homeodomain probe (193 base pairs (bp)) synthesized by
polymerase chain reaction (PCR) on Ncx cDNA using
primers (5'-ATCCCTACCAAAACCAAACC-3' and 5'-TTGGTGCGTCGGTTCTGGAA-3')
(9). Following hybridization, the filter was washed twice for 5 min
with 2× SSC and 0.1% SDS at room temperature and twice for 15 min
with 0.1× SSC and 0.1% SDS at 55 °C. The DIG-labeled probe was
detected with sheep anti-DIG antibody conjugated with alkaline
phosphatase. The antibody detection reaction was performed using an
enhanced chemiluminescent detection system (Roche Molecular Biochemicals).
Reverse Transcribed (RT)-PCR and Southern Blot
Analysis--
RT-PCR and Southern blot analysis were performed as
described elsewhere (9). Briefly, cDNAs were made by
reverse-transcribing total RNAs (100 ng) with oligo(dT) primers and
amplified 30 times with 2.5 units of Taq DNA polymerase, 2 mM MgCl2, 5% formamide, and the primers
(5'-TTTGCAAAGGACAGGCTCACG-3' and 5'-GGTGCAGCAGCAGGCGACCA-3') complementary to the murine Ncx cDNA. The PCR products
were separated on a 1% agarose gel and transferred onto a nylon
membrane (Amersham Pharmacia Biotech). The filter was hybridized
overnight with the DIG-labeled murine Ncx homeodomain probe
at 42 °C. The DIG-labeled probe was detected using the same method
described above.
Isolation of the Ncx Genomic Clones--
A murine Ncx
genomic clone was isolated from the 129/Sv genomic library, using the
murine Ncx homeodomain probe. A 10.0-kilobase pair (kb)
XbaI fragment of the genomic clone was inserted into pBluescript KS(
) (Stratagene). The human NCX cDNA was
isolated from the cDNA library of human neuroblastoma (SMS-KCN)
cells in
ZAPII (Stratagene), using the murine Ncx
homeodomain probe. A human NCX genomic clone was isolated
from a human placenta genomic library in
EMBL3 (Stratagene) with the
human NCX probe (a 241-bp BstXI/NotI
fragment in exon 1). A 6.8-kb HindIII fragment derived from
the human genomic clone was subcloned into pGEM-7Zf(+) (Promega).
Rapid Amplification of 5'-cDNA Ends (5'-RACE)
Analysis--
The 5'-RACE analysis was performed using the
5'AmpliFINDER RACE kit (CLONTECH). The
Ncx mRNAs in 2 µg of poly(A)+ RNA isolated
from the whole body of mouse embryos at embryonic day 12.5 using
oligo(dT)-cellulose columns (Life Technologies, Inc.) were
reverse-transcribed using the primer 5'-AAAACGCCGCACTTTCTCC-3', complementary to nucleotides between +151 and +133 of the
Ncx cDNA. The cDNA was mixed with 2.5 units of
Taq DNA polymerase, 1.5 mM MgCl2,
5% formamide, the primer (5'-GGATGACTGGAAAAGGTGTTTC-3'; complementary
to nucleotides between
21 and
42 of the Ncx cDNA), and the anchor primer for PCR. PCR was run for 1 min at 94 °C for
denaturing, 1 min at 60 °C for annealing, and 1 min at 72 °C for
extension. After 35 cycles of the PCR, the products were separated on a
1.5% agarose gel and stained with ethidium bromide. ~330-bp PCR
products were ligated with pGEM-T (Promega) for sequencing.
Primer Extension--
This analysis was made using by the method
described elsewhere (18). An oligonucleotide primer
(5'-AGTCCGCTCTGGGACTCGCAT-3'; complementary to nucleotides between
187 and
207 of the Ncx genomic sequence) was end-labeled
with [
-32P]ATP (Amersham Pharmacia Biotech). The
labeled primer was mixed with 15 µg of poly(A)+ RNA
isolated from the whole body of murine embryos at embryonic day 12.5 in
30 µl of hybridization buffer (40 mM PIPES, 1 mM EDTA, 0.4 M NaCl, 80% formamide) overnight
at 30 °C. 15 µg of transfer RNA was used as a negative control.
After ethanol precipitation, reverse transcription was performed at
37 °C for 1 h, and products were loaded onto a 6% sequencing
gel. Nucleotide sequencing of the murine genomic Ncx gene
was carried out by the dideoxy chain termination method using the same primer.
Reporter Gene Constructs--
To construct the 5'-flanking
region-luciferase fusion plasmid, a 7.0-kb BssHII fragment
(
7000/
73), a 3.3-kb PvuII-BssHII fragment
(
3300/
73), a 1.5-kb BamHI-BssHII fragment
(
1595/
73), and a 1.1-kb BstEII-BssHII
fragment (
1153/
73) were isolated from the murine Ncx
genomic clone and inserted into the pGL2 plasmid (Luc) carrying the
SV40 enhancer and the firefly luciferase reporter gene (Promega) to
generate the 7000NLuc, the 3300NLuc, the 1595NLuc, and the 1153NLuc
gene, respectively. The 1492NLuc, the 1414NLuc, the 1373NLuc, the
1238NLuc, and the 1195NLuc gene were obtained by progressive
exonuclease III deletion mutagenesis from the 1595NLuc plasmid with the
Erase-a-base system (Promega). The 1492MLuc and the 1414MLuc gene were
secured by deleting 10 bp (
1387/
1378) from the 1492NLuc and the
1414NLuc, using PCR, respectively.
Assay for the Promoter Activity with the Luciferase Reporter
Gene--
2.0 × 106 cells (C1300, B16, L, and
SH-SY5Y) were plated on a 100-mm dish 1 day before transfection. The
luciferase reporter plasmid (5 µg) and the sea pansy luciferase
expression vector, pRL-SV40 (0.25 µg) (TOYO INK, Tokyo, Japan), as a
transfection efficiency control, were co-transfected into those cells
using the DNA-calcium phosphate co-precipitation technique (19).
SV40Luc, the pGL2 plasmid with the SV40 promoter and enhancer and the
firefly luciferase reporter gene (Promega), was used for a positive
control. The transfected cells were incubated for 8 h, washed
three times with phosphate-buffered saline, and further cultured with
corresponding culture medium for 24 h. RA stimulation was given
8 h before harvesting. Luciferase activities in cell lysates were
determined using standard methods using the pikkagene dual (TOYO INK)
with luminometer (Lumat LB9507; Berthold). The firefly luciferase
activity from the reporter plasmids was normalized with the sea pansy
luciferase activity.
Preparation of Nuclear Extracts--
Nuclear extracts from
C1300, L, B16, and SH-SY5Y cells were prepared as described elsewhere
(20). Briefly, cultured cells were resuspended in hypotonic buffer.
After centrifugation, nuclei were resuspended in extraction buffer and
incubated on ice for 60 min. The amounts of protein in the supernatant
were estimated by micro-BCA protein assay (Pierce).
Electrophoretic Mobility Shift Assay (EMSA)--
EMSA was done
as described elsewhere (21). Briefly, the synthesized double-stranded
oligonucleotides were labeled with DIG using the DIG Oligonucleotide
3'-End Labeling kit (Roche Molecular Biochemicals). Binding reactions
were performed in a mixture containing 10 µg of nuclear proteins, 1 µg of poly(dI-dC)-poly(dI-dC) (Amersham Pharmacia Biotech), and 15 fM labeled probe in 21 µl of reaction buffer (10 mM HEPES, pH 7.8, 50 mM KCl, 1 mM
dithiothreitol, 50 µg/ml bovine serum albumin). The mixture was
incubated for 30 min at room temperature and separated on a 6%
nondenaturing polyacrylamide gel by electrophoresis in 0.25× TBE
buffer at 8 V/cm. Competitive EMSA was done by adding a 10- or 50-fold
molar excess of unlabeled double-stranded oligonucleotides to the
mixture. The double-stranded oligonucleotides used had the following
sequences:
1387/
1368, 5'-CCTGGCCCAGTCTTACCGGC-3';
1387/
1368
with a point mutation (m
1386),
5'-CATGGCCCAGTCTTACCGGC-3'; m
1384,
5'-CCTTGCCCAGTCTTACCGGC-3'; m
1382,
5'-CCTGGACCAGTCTTACCGGC-3'; m
1381,
5'-CCTGGCACAGTCTTACCGGC-3'; m
1380,
5'-CCTGGCCAAGTCTTACCGGC-3'; m
1379,
5'-CCTGGCCCCGTCTTACCGGC-3'; m
1378,
5'-CCTGGCCCATTCTTACCGGC-3'; m
1377,
5'-CCTGGCCCAGGCTTACCGGC-3'; m
1376,
5'-CCTGGCCCAGTATTACCGGC-3'; m
1375,
5'-CCTGGCCCAGTCGTACCGGC-3'; m
1374,
5'-CCTGGCCCAGTCTGACCGGC-3'; m
1373,
5'-CCTGGCCCAGTCTTCCCGGC-3'; m
1372,
5'-CCTGGCCCAGTCTTAACGGC-3'; m
1371,
5'-CCTGGCCCAGTCTTACAGGC-3'; m
1370,
5'-CCTGGCCCAGTCTTACCTGC-3'; m
1369,
5'-CCTGGCCCAGTCTTACCGTC-3'; m
1368,
5'-CCTGGCCCAGTCTTACCGGA-3'; and
1347/
1328,
5'-CCAGGGCCGGGGCGGGCTGG-3'.
 |
RESULTS |
Ncx Expression and Up-regulation with RA Stimulation in Neuronal
Lineage Cells--
The Ncx gene is specifically expressed
in a neuronal subset of neural crest derived tissues in murine embryos
(9, 10). To further determine the cell type-specific expression, we
examined the expression in several murine cell lines, using RT-PCR. The Ncx gene was expressed in C1300 neuroblastoma cells but not
in B16 melanoma cells, L fibroblast cells, and M12 B lymphoma cells (Fig. 1A). We then
investigated the NCX expression in several human
neuroblastoma cell lines (NBTM, SH-SY5Y, SMS-KCN, SK-N-AS, and GANB),
using Northern blot analysis; all expressed the NCX (Fig.
1B). PC12 rat pheochromocytoma cells also expressed the Ncx gene. (data not shown).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
Expression of Ncx
mRNA. A, expression of Ncx
mRNA in some murine cell lines was examined using RT-PCR and
Southern blots. Expression of G3PDH
(glyceraldehyde-3-phosphate dehydrogenase) mRNA is shown as a
control amount of the cDNA. B, expression of
NCX mRNA in human neuroblastoma cell lines was analyzed
in Northern blots. An autoradiograph of a blot (top) along
with a photograph (below) of the ethidium bromide-stained
gel is shown. 28 and 18 S ribosomal RNAs are marked.
|
|
RA stimulation induces differentiation of some cell lines and embryonic
tissues with expression of the Hox genes (22). Since RA
induced morphological differentiation in C1300 and SH-SY5Y neuroblastoma cell lines (23, 24), we examined the inducibility of
Ncx expression in those differentiating cells after RA
stimulation. As shown in Fig.
2A, the Ncx
expression was up-regulated to 10-fold of the prestimulation level in
C1300 cells at 2 h and then reverted to the prestimulation level
within 9 h later. In the SH-SY5Y cells, the NCX
expression was also up-regulated at 6 h and then down-regulated within 24 h later (Fig. 2B).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of Ncx mRNA
in neuroblastoma cell lines with RA stimulation. A,
Ncx expression in C1300 cells after all-trans-RA
(10 mM) stimulation was examined as described above. For
quantitation of the message, amounts of Ncx mRNA in 1 µg (×10), 100 ng (×1) and 10 ng
(× ) of total RNA from pretreated C1300 cells were examined
using RT-PCR. Expression of G3PDH mRNA is shown as a
control amount of the cDNA. B, NCX expression
in SH-SY5Y cells after all-trans-RA (10 mM)
stimulation was analyzed in Northern blots. An autoradiograph of a blot
(top) along with a photograph (below) of the
ethidium bromide-stained gel is shown. 28 and 18 S ribosomal RNAs are
marked.
|
|
Regulatory Elements in the 5'-Flanking Region of the Murine and the
Human NCX Gene--
To examine the regulatory elements for cell
type-specific expression and the RA responsibility of the
Ncx gene, we sequenced 1597 bp of the 5'-flanking region
with the translation start codon (Fig. 3)
and determined the transcription initiation site of the gene by primer
extension analysis and the 5'-RACE with poly(A)+ RNA from
the whole body of murine embryos. Fig. 4
shows that one initiation site was located 297 bp upstream from ATG
(+1). Comparison of the sequence of the 5'-RACE products to the genomic sequence confirmed that no intron existed on the 5'-flanking region from the ATG translation start codon (data not shown). When we compared
the 5'-flanking sequence with established consensus sequences in a
transcription factor data base, this regulatory region contained a
DR2-RARE, which consists of direct repeats of two motifs (AGGTCA) separated by 2 nucleotides (25), located in the region between
1163
and
1150 and the putative binding site of Sp1 (GGGGCGGGGT; at
positions
1463/
1452) and AP-1 (TGAGTCA; at positions
461/
455) (Fig. 3). However, the region lacked the conventional TATA box and the
CAAT box sequence.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide sequence of the 5'-flanking region
of the murine Ncx gene. Nucleotide numbering is
relative to the first nucleotide of the codon for the initiation
methionine (ATG; boxed with dotted line). The
transcription start site is marked with an arrow. Some
restriction endonuclease sites are underlined, and the
putative regulatory elements are boxed and
labeled.
|
|

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 4.
Primer extension analysis on the 5' end of
the murine Ncx gene. The autoradiograph shows a
primer extension on Ncx mRNA isolated from murine
embryos (E) along with dideoxy sequencing reactions (GATC)
of the murine genomic Ncx DNA. Transfer RNA (t)
was used as a negative control. The same primer was used for both
extension and sequencing reactions.
|
|
Since the NCX gene was also expressed and up-regulated with
RA stimulation in human neuroblastoma cell lines (Fig. 2B),
we sequenced 2169 bp of the 5'-flanking region from the translation start codon of the human genomic NCX gene. When the sequence
was compared with that from the mouse, the regions between
1397 and
1065 (Fig. 5) and between
682 and
522 (data not shown) in the murine Ncx gene were highly
conserved in the human NCX gene (
1517/
1187 and
801/
638, respectively). The region between
1517 and
1187 in the
human NCX gene also contained a DR2-RARE sequence
(
1283/
1270). These data suggest that these conserved regions are
important for regulation of the cell type-specific expression of the
Ncx gene.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison of the 5'-flanking sequence of the
murine Ncx gene with that of the human
NCX. The 5'-flanking region of murine
Ncx gene from 1397 to 1065 is highly conserved in that
of human NCX gene from 1517 to 1187. Identical matches
are denoted by dashes. Deleted nucleotides are indicated by
asterisks. The RAREs are boxed.
|
|
Functional Analysis of the Murine Ncx Promoter--
We next
analyzed a cell type-specific promoter activity in the 5'-flanking
region of the murine Ncx gene by transient transfection of
the promoter-reporter fusion genes into various cell lines. Various
lengths of the 5'-flanking region of the Ncx gene were fused
to the firefly luciferase gene. Since the endogenous Ncx was
expressed in SH-SY5Y and C1300 cells but not in B16 and L cells (Fig.
1), those chimeric constructs were transfected into those four cell
lines to examine the cell type-specific promoter activity (Fig.
6A). A significant increase
(3-8-fold) of the luciferase activity was observed in all four cell
lines when the 1153NLuc gene was transfected, suggesting the presence
of a minimal promoter element in the first 856 bp (
1153/
297) of
this 5'-flanking region. When the 1595NLuc construct was transfected
into SH-SY5Y and C1300 cells, the luciferase activity increased about
10-fold over the activity observed in the case of 1153NLuc
transfection. However, this augmentation was not detected in B16 and L
cells transfected with the 1595NLuc gene. Transfection of the 3300NLuc
and the 7000NLuc construct demonstrated almost the same activity as
that of the 1595NLuc, in all cell lines tested. These results suggested
that the region between
1595 and
1153 is important for cell
type-specific expression of the Ncx gene.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Murine Ncx promoter-reporter
constructs and their relative luciferase activity. A,
left, schematic representation of the reporter gene
constructs 7000NLuc, 3300NLuc, 1595NLuc, 1153NLuc, and Luc obtained by
deletions of the 5' region of the Ncx gene and SVLuc as a
positive control. Right, luciferase activity observed in
SH-SY5Y (hatched bars), C1300 (stippled bars),
B16 (closed bars), and L cells (open bars)
transfected with the different reporter genes. B,
left, schematic representation of the reporter gene
constructs 1595NLuc, 1492NLuc, 1414NLuc, 1373NLuc, 1238NLuc,
1195NLuc, 1153NLuc. RARE (open circles) and Sp1
(closed circles) on the 5'-flanking region of the
Ncx gene are indicated. Right, luciferase
activity observed in C1300 (stippled bars). The values are
the means of triplicate experiments from three independent studies. All
values are a percentage of activity of the construct Luc (1%), in
respective cell lines.
|
|
To further characterize the regulatory region of the murine
Ncx gene, a series of deletion clones from the region
between
1595 and
1153, prepared using the Erase-a-base system and
fused to the luciferase reporter gene, were transfected into C1300
cells (Fig. 6B). The region between
1373 and
1153 did
not enhance the promoter activity, irrespective of the presence of
RARE. The promoter activity of the constructs with the region between
1414 and
1153 was more than 7-fold higher than that with the region between
1373 and
1153. These findings suggest that the region between
1414 and
1374 plays an important role in determining enhancer activity in neuroblastoma cells of the Ncx gene.
A DNA Element for the Cell Type-specific Expression in the
5'-Flanking Region of the Murine Ncx Gene--
The reporter gene
analysis using a series of deletion clones in the 5'-flanking region
indicated that a DNA element regulating the cell type-specific
transcription of the Ncx gene was located in the region
between
1414 and
1374. Furthermore, the DNA sequence of the region
between
1397 and
1065 in the murine Ncx gene was highly
conserved in the human NCX gene. These observations strongly suggested that nuclear factors derived from neuroblastoma cells bound
to the region between
1397 and
1374 to regulate cell type-specific expression of the Ncx gene. To examine this possibility, we
synthesized three kinds of double-stranded oligonucleotides
(
1397/
1358,
1387/
1368, and
1377/
1338) that span this region
and did EMSA experiments with nuclear proteins from C1300, L, B16, and
SH-SY5Y cells. A specific band was detected in nuclear proteins from
C1300, SH-SY5Y, and B16 but not in proteins of L cells when the
1387/
1368 oligonucleotides were used (Fig.
7). This binding was inhibited with
unlabeled
1387/
1368 oligonucleotides but not with the unlabeled
1347/
1328 oligonucleotides in C1300 murine neuroblastoma cells (Fig. 8), suggesting that nuclear factors
bind to the DNA region between
1387 and
1368. In order to delineate
the binding site within the 20-bp element, we tested a series of
mutations in EMSA competition experiments. Unlabeled oligonucleotides
with a mutation at
1384 or
1373 could not inhibit the binding,
although oligonucleotides with a mutation at other sites could do so.
Similar results were obtained using nuclear proteins from SH-SY5Y human
neuroblastoma cells (data not shown). Therefore, the DNA element
between
1387 and
1368 controls the cell type-specific expression of
the Ncx, and nuclear factors that bind to this element are
present in cell lines derived from neural crest tissues in mouse and
human.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
EMSA of nuclear proteins interacting with the
DNA region between 1387 and 1368 of the murine Ncx
sequence. The labeled oligonucleotide ( 1387/ 1368) probe
was incubated with 10 µg of nuclear extracts from B16, L cell, C1300,
or SH-SY5Y.
|
|

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 8.
EMSA with various mutated oligonucleotides as
a competitor. A, the labeled oligonucleotide
( 1387/ 1368) probe was incubated with 10 µg of nuclear extracts
from C1300 murine neuroblastoma cell lines with various competitors.
For competition, 10-fold (+) or 50-fold (++) molar excess of the
unlabeled oligonucleotide 1387/ 1368 or 1347/ 1328 or mutated
oligonucleotides were used. 1387/ 1368-specific DNA-protein
complexes are indicated by arrows. B, a sequence
of the 20-bp element in mice and humans. Critical nucleotides for
factor binding are underlined.
|
|
Next we examined effects of this element on Ncx promoter
activity by preparing deletion mutants of the reporter plasmids. Deletion from
1387 to
1368 was introduced to the 1492NLuc and the
1414NLuc reporter plasmid (1492MLuc and 1414MLuc, respectively), and
the promoter activity of those plasmids in C1300 neuroblastoma cells
was measured. When the 1492MLuc or the 1414MLuc reporter plasmid was
transfected, luciferase activity dramatically decreased to
-
-fold compared with the case of wild type
reporter plasmids (Fig. 9). These results also confirm that the DNA element from
1387 to
1368 is required for
display of the proper expression level of the Ncx gene in neural crest-derived cells.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Murine Ncx promoter-reporter constructs with
deletion of a part of the enhancer element ( 1387/ 1368) and their
relative luciferase activity. Left, schematic
representation of the reporter gene constructs 1492NLuc, 1492MLuc,
1414NLuc, 1414MLuc, and 1373NLuc. Right, luciferase activity
observed in C1300 transfected with different reporter genes. The values
are means of triplicate experiments from three independent
studies.
|
|
 |
DISCUSSION |
Expression of the Ncx gene is tightly regulated in
neuronal lineage of neural crest-derived tissues (9, 10). We confirmed the tissue-specific expression of Ncx in various cell lines,
using a sensitive RT-PCR assay. This gene was expressed in neuronal cells derived from the neural crest such as neuroblastoma cell lines
but not in fibroblast and B lymphoma cells. Although melanocytes are
derived from the neural crest (11), the expression was never detected
in B16 murine melanoma cells. Therefore, we attempted to identify the
regulatory region governing the tissue-specific expression in the
5'-flanking region of the Ncx gene, and for this we
transfected promoter-reporter fusion genes into those cell lines.
First, we sequenced 5'-flanking regions of the murine and the human
Ncx gene. Neither the TATA box nor the CAAT box consensus
sequence was identified in the 5'-flanking regions of murine and human
Ncx genes. The promoter regions of Hoxa-4 (26), Hoxb-4 (27), Hoxc-4 (28), Hoxc-6 (29),
and Hoxc-8 (30) also lack the TATA box. Transient
transfection experiments (Fig. 6A) suggest that the minimal
promoter element of the murine Ncx gene locates in the
region between
1153 and
73. The regions between
1153 and
1065
and between
682 and
522 in the Ncx gene were highly
conserved in humans (data not shown), suggesting a presence of the
common basic regulatory element in those regions. However, none of the
known consensus sequence was found in those regions.
Second, we found that the region between
1414 and
1373 of the
murine Ncx gene plays an important role in determining its cell type-specific expression (Fig. 6B). Furthermore, we
found that a putative nuclear factor specifically bound to the region between
1387 and
1368, as determined by EMSA (Fig. 7), and
nucleotides at the position
1384 or
1373 are critical for the
binding. The sequence of this region, highly conserved between murine
and human, does not resemble any known consensus bindng sequence of
transcription factors by data base search. This factor was detected in
nuclear proteins from not only murine and human neuroblastoma cell
lines but also the B16 melanoma cell line. However, it was not detected in nuclear proteins from L fibroblast cells. Therefore, the DNA region
between
1387 and
1368 may be the element for determining the neural
crest tissue-specific expression of Ncx. Since the promoter
activity was only enhanced in neuroblastoma cells and not in the B16
melanoma cell line, additional nuclear factors specific to the neuronal
lineage cells are required to control lineage-restricted expression of
the Ncx gene of neural crest-derived cells. Further
characterization of this factor may reveal not only the molecular
mechanism of tissue-specific expression of the Ncx gene but
also mechanisms related to lineage commitment of neural crest to
neuronal cells.
Ncx expression was augmented in C1300 or SH-SY5Y cells with
RA stimulation. The 5'-flanking regions of the human and the murine Ncx gene carried the DR2-RARE. When C1300 cells were
transfected with the 1298NLuc construct containing RARE and stimulated
with RA to examine the inducibility, the luciferase activity with RA stimulation was up-regulated 3-fold above that without RA stimulation (data not shown), suggesting that this RARE is functional. Several Hox genes also have RARE in their noncoding region (31). For example, the 3'-flanking sequence of the Hoxa-1 gene has the
DR5-RARE, the direct repeats separated by 5 nucleotides, that regulate
its expression (32). The Hoxb-1 gene has two DR2-RAREs,
which locate in the 5'- and 3'-flanking regions. RARE in the
3'-flanking region functions as a tissue-specific enhancer. Point
mutation of RARE in the 3' side prevented the neuronal expression of
Hoxb-1 in transgenic mice (33). On the other hand, RARE in
the 5'-flanking region is an essential component of the repressor
element to refine the Hoxb-1 expression to hind brain (34).
Thus, those two RAREs control the tissue-specific expression of the
Hoxb-1 gene. Although RARE in the 5'-flanking region of the
Ncx gene is functional in neuroblastoma cells (Fig. 2), RARE
is not essential for the cell type-specific expression of the
Ncx gene in vitro (Fig. 6B). Further in vivo studies using transgenic mice should reveal the
precise function of this RARE element.
RA is known to induce differentiation in some neuroblastoma cell lines.
Both C1300 and SH-SY5Y underwent morphological changes upon stimulation
with RA, and expression of Ncx was up-regulated in these
cells after the stimulation. To examine the relation between the
expression of Ncx and neuronal differentiation,
differentiation was induced in neuroblastoma cell lines by various
stimuli other than RA. C1300 cells are known to differentiate after
serum deprivation (35). However, Ncx expression in C1300
cells was not induced after serum deprivation; rather, it was
down-regulated (data not shown). SH-SY5Y cells differentiate upon nerve
growth factor stimulation (36). During the differentiation after nerve
growth factor stimulation, the amount of the NCX message
remained unchanged (data not shown). Moreover, the
Ncx-deficient mice showed normal differentiation of neural
crest-derived neurons such as dorsal root ganglia, trigeminus ganglia,
and enteric ganglia (10, 14). Therefore, Ncx is not directly related to
neuronal differentiation and may not be essential for differentiation
of neural crest lineage cells.
Several transcriptional factors important for differentiation of neural
crest have been identified, and most act as a master gene for lineage
determination of neural crest cells. The Mash1 (mammalian
achaete-scute homologue 1) gene, encoding basic helix-loop-helix transcription factor, is expressed only in precursors of all autonomic neurons, not in those of sensory neurons (37). A targeted mutation in
Mash1 blocks the development of sympathetic,
parasympathetic, and a subset of enteric neurons (38), indicating that
this gene product plays a critical role in autonomic neurogenesis. The
Neurogenin 1 (39) and the neurogenin 2 (also
known as Math4A) (40), expressed in sensory but not in
autonomic ganglia, are thought to be important for lineage
determination of sensory cells. The Ncx gene is expressed in
all of the neuronal lineage derived from neural crest (9). Data
presented here demonstrate that the DNA element (between
1387 and
1368) located in the 5'-flanking region of the Ncx gene is
critical for enhancer activity in neuroblastoma cells. In
Ncx-deficient mice, megacolon, which occurs with an
increased number of enteric neurons, resembles neuronal intestinal
dysplasia, a disease in humans (10, 14). Further characterization of a
regulatory mechanism of tissue-specific expression of Ncx
should reveal a genetic basis of this disease.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. T. Matsumura for the
gift of C1300 cell lines and Dr. A. Nakagawara for helpful discussion
and for providing the five human neuroblastoma cell lines. We also
thank H. Satake for skillful technical assistance, N. Fujita for
secretarial assistance, and M. Ohara for comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by a grant-in-aid for scientific
research on priority areas from the Ministry of Education, Science, Sports and Culture, Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB008500 (the 5'-flanking region of the murine Ncx), AB008501 (the human NCX cDNA), and AB008502 (the 5'-flanking region of the
human NCX).
¶
To whom correspondence should be addressed: Dept. of
Developmental Genetics, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Tel.: 81-43-226-2182; Fax: 81-43-226-2183; E-mail: hatano@med.m.chiba-u.ac.jp.
2
Y. Iitsuka, H. Shimizu, M. M. Kang, K. Sasagawa, S. Sekiya, T. Tokuhisa, and M. Hatano, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
RARE, retinoic acid
response element;
RA retinoic acid, DIG, digoxigenin;
bp, base pair(s);
PCR, polymerase chain reaction;
RT-PCR, reverse transcribed polymerase
chain reaction;
kb, kilobase pair(s);
5'-RACE, rapid amplification of
5'-cDNA ends;
EMSA, electrophoretic mobility shift assay.
 |
REFERENCES |
| 1.
|
Krumlauf, R.
(1994)
Cell
78,
191-201[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Dear, T. N.,
Sanchez-Garcia, I.,
and Rabbitts, T. H.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
4431-4435[Abstract/Free Full Text]
|
| 3.
|
Raju, K.,
Tang, S.,
Dubé, I. D.,
Kamel-Reid, S.,
Bryce, D. M.,
and Breitman, M. L.
(1993)
Mech. Dev.
44,
51-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dubé, I. D.,
Kamel-Reid, S.,
Yuan, C. C.,
Lu, M.,
Wu, X.,
Corpus, G.,
Raimondi, S. C.,
Crist, W. M.,
Carroll, A. J.,
Minowada, J.,
and Baker, J. B.
(1991)
Blood
78,
2996-3003[Abstract/Free Full Text]
|
| 5.
|
Hatano, M.,
Roberts, C. W.,
Minden, M.,
Crist, W. M.,
and Korsmeyer, S. J.
(1991)
Science
253,
79-82[Abstract/Free Full Text]
|
| 6.
|
Kennedy, M. A.,
Gonzalez-Sarmiento, R.,
Kees, U. R.,
Lampert, F.,
Dear, N.,
Boehm, T.,
and Rabbitts, T. H.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8900-8904[Abstract/Free Full Text]
|
| 7.
|
Lu, M.,
Gong, Z. Y.,
Shen, W. F.,
and Ho, A. D.
(1991)
EMBO J.
10,
2905-2910[Medline]
[Order article via Infotrieve]
|
| 8.
|
Wen, X. Y.,
Tang, S.,
and Breitman, M. L.
(1994)
Genomics
24,
388-390[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hatano, M.,
Iitsuka, Y.,
Yamamoto, H.,
Dezawa, M.,
Yusa, S.,
Kohno, Y.,
and Tokuhisa, T.
(1997)
Anat. Embryol.
195,
419-425[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Shirasawa, S.,
Yunker, A. M.,
Roth, K. A.,
Brown, G. A.,
Horning, S.,
and Korsmeyer, S. J.
(1997)
Nat. Med.
3,
646-650[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Selleck, M. A.,
Scherson, T. Y.,
and Bronner-Fraser, M.
(1993)
Dev. Biol.
159,
1-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Kamps, M. P.,
Murre, C.,
Sun, X. H.,
and Baltimore, D.
(1990)
Cell
60,
547-555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nourse, J.,
Mellentin, J. D.,
Galili, N.,
Wilkinson, J.,
Stanbridge, E.,
Smith, S. D.,
and Cleary, M. L.
(1990)
Cell
60,
535-545[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Hatano, M.,
Aoki, T.,
Dezawa, M.,
Yusa, S.,
Iitsuka, Y.,
Koseki, H.,
Taniguchi, M.,
and Tokuhisa, T.
(1997)
J. Clin. Invest.
100,
795-801[Medline]
[Order article via Infotrieve]
|
| 15.
|
Hammerling, U.,
Bjelfman, C.,
and Pahlman, S.
(1987)
Oncogene
2,
73-77[Medline]
[Order article via Infotrieve]
|
| 16.
|
Nakagawara, A.,
Azar, C. G.,
Scavarda, N. J.,
and Brodeur, G. M.
(1994)
Mol. Cell. Biol.
14,
759-767[Abstract/Free Full Text]
|
| 17.
|
Cohen, P. S.,
Letterio, J. J.,
Gaetano, C.,
Chan, J.,
Matsumoto, K.,
Sporn, M. B.,
and Thiele, C. J.
(1995)
Cancer Res.
55,
2380-2386[Abstract/Free Full Text]
|
| 18.
|
Arai, Y.,
Hatano, M.,
and Tokuhisa, T.
(1997)
Gene (Amst.)
193,
73-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, p. 16.32, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 20.
|
Ochi, Y.,
Koizumi, T.,
Kobayashi, S.,
Phuchareon, J.,
Hatano, M.,
Takada, M.,
Tomita, Y.,
and Tokuhisa, T.
(1994)
J. Immunol.
153,
3485-3490[Abstract]
|
| 21.
|
Yoshida, T.,
Fukuda, T.,
Okabe, S.,
Hatano, M.,
Miki, T.,
Hirosawa, S.,
Miyasaka, N.,
Isono, K.,
and Tokuhisa, T.
(1996)
Biochem. Biophys. Res. Commun.
228,
216-220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Marshall, H.,
Morrison, A.,
Studer, M.,
Popperl, H.,
and Krumlauf, R.
(1996)
FASEB J.
10,
969-978[Abstract]
|
| 23.
|
Riboni, L.,
Prinetti, A.,
Bassi, R.,
Caminiti, A.,
and Tettamanti, G.
(1995)
J. Biol. Chem.
270,
26868-26875[Abstract/Free Full Text]
|
| 24.
|
Pahlman, S.,
Ruusala, A. I.,
Abrahamsson, L.,
Mattsson, M. E.,
and Esscher, T.
(1984)
Cell Differ.
14,
135-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Durand, B.,
Saunders, M.,
Leroy, P.,
Leid, M.,
and Chambon, P.
(1992)
Cell
71,
73-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Galliot, B.,
Dolle, P.,
Vigneron, M.,
Featherstone, M. S.,
Baron, A.,
and Duboule, D.
(1989)
Development
107,
343-359[Abstract]
|
| 27.
|
Gutman, A.,
Gilthorpe, J.,
and Rigby, P. W.
(1994)
Mol. Cell. Biol.
14,
8143-8154[Abstract/Free Full Text]
|
| 28.
|
Geada, A. M.,
Gaunt, S. J.,
Azzawi, M.,
Shimeld, S. M.,
Pearce, J.,
and Sharpe, P. T.
(1992)
Development
116,
497-506[Medline]
[Order article via Infotrieve]
|
| 29.
|
Coletta, P. L.,
Shimeld, S. M.,
Chaudhuri, C.,
Muller, U.,
Clarke, J. P.,
and Sharpe, P. T.
(1991)
Mech. Dev.
35,
129-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Awgulewitsch, A.,
Bieberich, C.,
Bogarad, L.,
Shashikant, C.,
and Ruddle, F. H.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6428-6432[Abstract/Free Full Text]
|
| 31.
|
De Luca, L. M.
(1991)
FASEB J.
5,
2924-2933[Abstract]
|
| 32.
|
Langston, A. W.,
and Gudas, L. J.
(1992)
Mech. Dev.
38,
217-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Marshall, H.,
Studer, M.,
Popperl, H.,
Aparicio, S.,
Kuroiwa, A.,
Brenner, S.,
and Krumlauf, R.
(1994)
Nature
370,
567-571[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Studer, M.,
Popperl, H.,
Marshall, H.,
Kuroiwa, A.,
and Krumlauf, R.
(1994)
Science
265,
1728-1732[Abstract/Free Full Text]
|
| 35.
|
Maltese, W. A.,
Reitz, B. A.,
and Volpe, J. J.
(1981)
J. Cell. Physiol.
108,
475-482[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Sonnenfeld, K. H.,
and Ishii, D. N.
(1982)
J. Neurosci. Res.
8,
375-391[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Lo, L. C.,
Johnson, J. E.,
Wuenschell, C. W.,
Saito, T.,
and Anderson, D. J.
(1991)
Genes Dev.
5,
1524-1537[Abstract/Free Full Text]
|
| 38.
|
Guillemot, F.,
Lo, L. C.,
Johnson, J. E.,
Auerbach, A.,
Anderson, D. J.,
and Joyner, A. L.
(1993)
Cell
75,
463-476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Ma, Q.,
Kintner, C.,
and Anderson, D. J.
(1996)
Cell
87,
43-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Sommer, L.,
Ma, Q.,
and Anderson, D. J.
(1996)
J. Mol. Cell. Neurosci.
8,
221-241
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?